Santiago Vilar - Citegraph

Author Info

Name	Affiliation	Papers
SANTIAGO VILAR	Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA	13
Collaborators	Citations	PageRank
20	106	9.12
Referers	Referees	References
405	421	132

Search Limit

100421

Publications (13 rows)

Collaborators (20 rows)

Referers (100 rows)

Referees (100 rows)

Title	Citations	PageRank	Year
Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.	5	0.42	2018
The role of drug profiles as similarity metrics: applications to repurposing, adverse effects detection and drug-drug interactions.	4	0.38	2017
Leveraging 3D chemical similarity, target and phenotypic data in the identification of drug-protein and drug-adverse effect associations.	3	0.38	2016
A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records.	10	0.56	2014
Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions.	37	2.02	2013
In Silico Screening For Agonists And Blockers Of The Beta(2) Adrenergic Receptor: Implications Of Inactive And Activated State Structures	2	0.46	2012
Drug-drug interaction through molecular structure similarity analysis.	29	1.15	2012
Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.	9	1.35	2011
Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta2-adrenergic receptor	0	0.34	2010
QSAR model for alignment-free prediction of human breast cancer biomarkers based on electrostatic potentials of protein pseudofolding HP-lattice networks.	4	0.81	2008
Inhibitor docking screened by the modified SAFE_p scoring function: application to cyclic urea HIV-1 PR inhibitors.	1	0.50	2007
In Silico Studies toward the Discovery of New Anti-HIV Nucleoside Compounds through the Use of TOPS-MODE and 2D/3D Connectivity Indices. 2. Purine Derivatives.	0	0.34	2005
In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives.	2	0.42	2002

1